Life Science
Click to enlarge
Home » Our Report Repository » Topical Pain Relief Market Analysis and Global Forecast (2021-2028) with COVID Impact Analysis
Synthetic Fabric Market Analysis and Global Forecast (2021-2028) with COVID Impact Analysis $ 3,475.00
Back to products
Rubber Muffler Hanger
Test Demo $ 1,999.00 – $ 2,799.00

Topical Pain Relief Market Analysis and Global Forecast (2021-2028) with COVID Impact Analysis

$ 3,475.00

Topical Pain Relief Market By Therapeutic Class (Non-opioids, Opioids), By Type (Prescription Pain Relief, Over-the-counter (OTC) Pain Relief), By Distribution Channel(Pharmacy & Drug Store, e-Commerce, Retail & Grocery Store) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028

Report Code: EB_LS_311| Page: 155 | Published Date: March 2021

Categories: ,
Description

The global Topical Pain Relief market size is expected to reach $13.3 Billion by 2028 growing at the CAGR of 5.44% from 2021 to 2028. This growth is attributed to several macro and micro economic factors such as

  • Increase in prevalence of arthritis and other bone-related conditions
  • Driver 2

 

Further several factors restraining the market growth include

  • Restraint1
  • Restraint 2

 

Collaborations and Alliances in the Topical Pain Relief market is expected to generate higher avenues during the forecast period.

The COVID-19 pandemic has led to supply chain disruptions leading to supply shortages or lower demand in the Topical Pain Relief market. The travel restrictions and social-distancing measures have resulted in a sharp drop in consumer and business spending and this pattern is to continue for some time. The end-user trend and preferences have changed due to the pandemic and have resulted in manufacturers, developers, and service providers to adopt various strategies to stabilize the company.

 

In terms of COVID 19 impact, the Topical Pain Relief market report also includes following data points:

  • Impact on Topical Pain Relief market size
  • End User Trend, Preferences and Budget Impact
  • Regulatory Framework/Government Policies
  • Key Players Strategy to Tackle Negative Impact/Post-COVID Strategies
  • Opportunity in Topical Pain Relief market

 

Key Insight in the report:

The global Topical Pain Relief market report covers executive summary, market dynamics, COVID impact & post COVID scenario, market size and forecast, competitive intelligence, market positioning, and product offerings.

Our report covers extensive competitive intelligence which include following data points:

  • Business Overview
  • Business Segment Data
  • Financial Data
  • Product Segment Analysis and Specification
  • Recent Development and Company Strategy Analysis
  • SWOT Analysis

 

The report covers market sizing and forecasting at the country level as well as at the segment level. Topical Pain Relief market is analyzed across below-mentioned different segments:

  • Therapeutic Class
    • Non-opioids
    • Opioids
  • Type
    • Prescription Pain Relief
    • Over-the-counter Pain Relief
    • Type 3
    • Type 4
  • Distribution Channel
    • Pharmacy & Drug Store
    • e-Commerce
    • Retail & Grocery Store

 

Topical Pain Relief market is also analyzed across below-mentioned regions/countries:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Rest of Asia Pacific
  • Rest of the World
    • South America
    • Middle East & Africa

 

Some of the key players in of Topical Pain Relief market include:

  • Advacare Pharma
  • Glaxosmithkline Plc
  • Johnson & Johnson
  • Nestlé
  • Novartis AG
  • Pfizer Inc
  • Reckitt Benckiser Group Plc
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Topical Biomedics, Inc.

 

REPORT CONTENT BRIEF:

  • High level analysis of the current and future market trends and opportunities
  • Detailed analysis on current market drivers, restraining factors, and opportunities in the future
  • Topical Pain Relief market estimates for 2020 and forecast from 2021 to 2028
  • Vendor market share analysis at each product level
  • Competitor analysis with a detailed insight into its product segment, financial strength, and strategies adopted.
  • Identifies key strategies adopted including product launches and developments, mergers and acquisitions, joint ventures, collaborations and partnerships as well as funding taken and investment done, among others.

 

Target Audience

  • Manufacturers
  • Suppliers and traders
  • Government, associations, and industrial bodies
  • Investors and trade experts
  • Consulting Firms or Individual Consultant
  • Anyone interested in understanding industry dynamic of Topical Pain Relief market

For more details mail us at

Ask a question / additional requirement













    Press Release

    Table of Content

    Table of Content

    Chapter 1.   Executive Summary

     

    Chapter 2.   Scope Of The Study

                         2.1.   Market Definition

                         2.2.   Scope Of The Study

                                   2.2.1.   Objectives of Report

     

    Chapter 3.   Evolve BI Methodology

     

    Chapter 4.   Market Insights and Trends

                         4.1.   Supply/ Value Chain Analysis

                         4.2.   Porter’s Five Forces Analysis

                                   4.2.1.   Threat Of New Entrants

                                   4.2.2.   Bargaining Power Of Buyers

                                   4.2.3.   Bargaining Power Of Suppliers

                                   4.2.4.   Threat Of Substitutes

                                   4.2.5.   Industry Rivalry

                         4.3.   Impact of COVID-19 on Topical Pain Relief Market

                                   4.3.1.   Impact on Market Size

                                   4.3.2.   End User Trend, Preferences and Budget Impact

                                   4.3.3.   Regulatory Framework/Government Policies

                                   4.3.4.   Key Players Strategy to Tackle Negative Impact

                                   4.3.5.   Opportunity Window

     

    Chapter 5.   Market Dynamics

                         5.1.   Introduction

                         5.2.   DRO Analysis

                                   5.2.1.   Drivers

                                   5.2.2.   Restraints

                                   5.2.3.   Opportunities

     

    Chapter 6.   Global Topical Pain Relief Market, By Therapeutic Class

                         6.1.   Introduction

                         6.2.   Non-opioids

                         6.3.   Opioids

     

    Chapter 7.   Global Topical Pain Relief Market, By Type

                         7.1.   Introduction

                         7.2.   Prescription Pain Relief

                         7.3.   Over-the-counter Pain Relief

     

    Chapter 8.   Global Topical Pain Relief Market, By Distribution Channel

                         8.1.   Introduction

                         8.2.   Pharmacy & Drug Store

                         8.3.   e-Commerce

                         8.4.   Retail & Grocery Store

     

    Chapter 9.   Global Topical Pain Relief Market, By Region

                         9.1.   Introduction

                         9.2.   North America

                                   9.2.1.   Introduction

                                   9.2.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                   9.2.3.   Market Size and Forecast, By Country, 2020 - 2028

                                   9.2.4.   Market Size and Forecast, By Therapeutic Class, 2020 - 2028

                                   9.2.5.   Market Size and Forecast, By Type, 2020 - 2028

                                   9.2.6.   Market Size and Forecast, By Distribution Channel, 2020 - 2028

                                   9.2.7.   US

                                                  9.2.7.1.   Introduction

                                                  9.2.7.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                                  9.2.7.3.   Market Size and Forecast, By Therapeutic Class, 2020 - 2028

                                                  9.2.7.4.   Market Size and Forecast, By Type, 2020 - 2028

                                                  9.2.7.5.   Market Size and Forecast, By Distribution Channel, 2020 - 2028

                                   9.2.8.   Canada

                                                  9.2.8.1.   Introduction

                                                  9.2.8.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                                  9.2.8.4.   Market Size and Forecast, By Therapeutic Class, 2020 - 2028

                                                  9.2.8.5.   Market Size and Forecast, By Type, 2020 - 2028

                                                  9.2.8.6.   Market Size and Forecast, By Distribution Channel, 2020 - 2028

                         9.3.   Europe

                                   9.3.1.   Introduction

                                   9.3.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                   9.3.3.   Market Size and Forecast, By Country, 2020 - 2028

                                   9.3.4.   Market Size and Forecast, By Therapeutic Class, 2020 - 2028

                                   9.3.5.   Market Size and Forecast, By Type, 2020 - 2028

                                   9.3.6.   Market Size and Forecast, By Distribution Channel, 2020 - 2028

                                   9.3.7.   Germany

                                                  9.3.7.1.   Introduction

                                                  9.3.7.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                                  9.3.7.3.   Market Size and Forecast, By Therapeutic Class, 2020 - 2028

                                                  9.3.7.4.   Market Size and Forecast, By Type, 2020 - 2028

                                                  9.3.7.5.   Market Size and Forecast, By Distribution Channel, 2020 - 2028

                                   9.3.8.   France

                                                  9.3.8.1.   Introduction

                                                  9.3.8.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                                  9.3.8.3.   Market Size and Forecast, By Therapeutic Class, 2020 - 2028

                                                  9.3.8.4.   Market Size and Forecast, By Type, 2020 - 2028

                                                  9.3.8.5.   Market Size and Forecast, By Distribution Channel, 2020 - 2028

                                   9.3.9.   UK

                                                  9.3.9.1.   Introduction

                                                  9.3.9.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                                  9.3.9.3.   Market Size and Forecast, By Therapeutic Class, 2020 - 2028

                                                  9.3.9.4.   Market Size and Forecast, By Type, 2020 - 2028

                                                  9.3.9.5.   Market Size and Forecast, By Distribution Channel, 2020 - 2028

                                   9.3.10.   Italy

                                                  9.3.10.1.   Introduction

                                                  9.3.10.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                                  9.3.10.3.   Market Size and Forecast, By Therapeutic Class, 2020 - 2028

                                                  9.3.10.4.   Market Size and Forecast, By Type, 2020 - 2028

                                                  9.3.10.5.   Market Size and Forecast, By Distribution Channel, 2020 - 2028

                                   9.3.11.   Rest Of Europe

                                                  9.3.11.1.   Introduction

                                                  9.3.11.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                                  9.3.11.3.   Market Size and Forecast, By Therapeutic Class, 2020 - 2028

                                                  9.3.11.4.   Market Size and Forecast, By Type, 2020 - 2028

                                                  9.3.11.5.   Market Size and Forecast, By Distribution Channel, 2020 - 2028

                         9.4.   Asia-Pacific

                                   9.4.1.   Introduction

                                   9.4.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                   9.4.3.   Market Size and Forecast, By Country, 2020 - 2028

                                   9.4.4.   Market Size and Forecast, By Therapeutic Class, 2020 - 2028

                                   9.4.5.   Market Size and Forecast, By Type, 2020 - 2028

                                   9.4.7.   Market Size and Forecast, By Distribution Channel, 2020 - 2028

                                   9.4.8.   China

                                                  9.4.8.1.   Introduction

                                                  9.4.8.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                                  9.4.8.3.   Market Size and Forecast, By Therapeutic Class, 2020 - 2028

                                                  9.4.8.4.   Market Size and Forecast, By Type, 2020 - 2028

                                                  9.4.8.5.   Market Size and Forecast, By Distribution Channel, 2020 - 2028

                                   9.4.9.   India

                                                  9.4.9.1.   Introduction

                                                  9.4.9.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                                  9.4.9.3.   Market Size and Forecast, By Therapeutic Class, 2020 - 2028

                                                  9.4.9.4.   Market Size and Forecast, By Type, 2020 - 2028

                                                  9.4.9.5.   Market Size and Forecast, By Distribution Channel, 2020 - 2028

                                   9.4.10.   Japan

                                                  9.4.10.1.   Introduction

                                                  9.4.10.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                                  9.4.10.3.   Market Size and Forecast, By Therapeutic Class, 2020 - 2028

                                                  9.4.10.4.   Market Size and Forecast, By Type, 2020 - 2028

                                                  9.4.10.5.   Market Size and Forecast, By Distribution Channel, 2020 - 2028

                                   9.4.11.   South Korea

                                                  9.4.11.1.   Introduction

                                                  9.4.11.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                                  9.4.11.3.   Market Size and Forecast, By Therapeutic Class, 2020 - 2028

                                                  9.4.11.4.   Market Size and Forecast, By Type, 2020 - 2028

                                                  9.4.11.5.   Market Size and Forecast, By Distribution Channel, 2020 - 2028

                                   9.4.12.   Rest Of Asia-Pacific

                                                  9.4.11.1.   Introduction

                                                  9.4.12.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                                  9.4.12.3.   Market Size and Forecast, By Therapeutic Class, 2020 - 2028

                                                  9.4.12.4.   Market Size and Forecast, By Type, 2020 - 2028

                                                  9.4.12.5.   Market Size and Forecast, By Distribution Channel, 2020 - 2028

                         9.5.   Rest Of The World (RoW)

                                   9.5.1.   Introduction

                                   9.5.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                   9.5.3.   Market Size and Forecast, By Therapeutic Class, 2020 - 2028

                                   9.5.4.   Market Size and Forecast, By Type, 2020 - 2028

                                   9.5.5.   Market Size and Forecast, By Distribution Channel, 2020 - 2028

                                   9.5.6.   Market Size and Forecast, By Region, 2020 - 2028

                                   9.5.7.   South America

                                                  9.5.7.1.   Introduction

                                                  9.5.7.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                                  9.5.7.3.   Market Size and Forecast, By Therapeutic Class, 2020 - 2028

                                                  9.5.7.4.   Market Size and Forecast, By Type, 2020 - 2028

                                                  9.5.7.5.   Market Size and Forecast, By Distribution Channel, 2020 - 2028

                                   9.5.8.   Middle East & Africa

                                                  9.5.8.1.   Introduction

                                                  9.5.8.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                                  9.5.8.3.   Market Size and Forecast, By Therapeutic Class, 2020 - 2028

                                                  9.5.8.4.   Market Size and Forecast, By Type, 2020 - 2028

                                                  9.5.8.5.   Market Size and Forecast, By Distribution Channel, 2020 - 2028

     

    Chapter 10.   Competitive Landscape

                         10.1.   Introduction

                         10.2.   Vendor Share Analysis, 2020/Key Players Positioning 2020

     

    Chapter 11.   Company Profiles

                         11.1.    Advacare Pharma

                                   11.1.1.   Business Overview

                                   11.1.2.   Financial Analysis

                                   11.1.3.   Product Portfolio

                                   11.1.4.   Recent Development and Strategies Adopted

                                   11.1.5.   SWOT Analysis

                         11.2.   Glaxosmithkline Plc

                                   11.2.1.   Business Overview

                                   11.2.2.   Financial Analysis

                                   11.2.3.   Product Portfolio

                                   11.2.4.   Recent Development and Strategies Adopted

                                   11.2.5.   SWOT Analysis

                         11.3.   Johnson & Johnson

                                   11.3.1.   Business Overview

                                   11.3.2.   Financial Analysis

                                   11.3.3.   Product Portfolio

                                   11.3.4.   Recent Development and Strategies Adopted

                                   11.3.5.   SWOT Analysis

                         11.4.   Nestlé

                                   11.4.1.   Business Overview

                                   11.4.2.   Financial Analysis

                                   11.4.3.   Product Portfolio

                                   11.4.4.   Recent Development and Strategies Adopted

                                   11.4.5.   SWOT Analysis

                         11.5.   Novartis AG

                                   11.5.1.   Business Overview

                                   11.5.2.   Financial Analysis

                                   11.5.3.   Product Portfolio

                                   11.5.4.   Recent Development and Strategies Adopted

                                   11.5.5.   SWOT Analysis

                         11.6.    Pfizer Inc

                                   11.6.1.   Business Overview

                                   11.6.2.   Financial Analysis

                                   11.6.3.   Product Portfolio

                                   11.6.4.   Recent Development and Strategies Adopted

                                   11.6.5.   SWOT Analysis

                         11.7.    Reckitt Benckiser Group Plc

                                   11.7.1.   Business Overview

                                   11.7.2.   Financial Analysis

                                   11.7.3.   Product Portfolio

                                   11.7.4.   Recent Development and Strategies Adopted

                                   11.7.5.   SWOT Analysis

                         11.8.    Sanofi

                                   11.8.1.   Business Overview

                                   11.8.2.   Financial Analysis

                                   11.8.3.   Product Portfolio

                                   11.8.4.   Recent Development and Strategies Adopted

                                   11.8.5.   SWOT Analysis

                         11.9.   Sun Pharmaceutical Industries Ltd.

                                   11.9.1.   Business Overview

                                   11.9.2.   Financial Analysis

                                   11.9.3.   Product Portfolio

                                   11.9.4.   Recent Development and Strategies Adopted

                                   11.9.5.   SWOT Analysis

                         11.10.    Topical Biomedics, Inc.

                                   11.10.1.   Business Overview

                                   11.10.2.   Financial Analysis

                                   11.10.3.   Product Portfolio

                                   11.9.4.   Recent Development and Strategies Adopted

                                   11.9.5.   SWOT Analysis

     

    Chapter 12.   Key Takeaways

    Connect to Analyst

    Connect to Analyst













      Research Methodology

      Research Methodology

      Related products

      Healthcare

      Global Gene Therapy Market

      $ 3,475.00
      Gene Therapy Market By Therapy Type (Somatic, Germline) By Vector Type (Non-Viral Vectors, Viral Vectors) By Application (Cancer Diseases, Monogenic Diseases, Infectious Diseases, Cardiovascular Diseases, Others) and By Geography: Global trends, opportunities and forecast – 2020 to 2027
      Add to cart
      Quick view
      Life Science

      Wearable Patch Market Analysis and Global Forecast (2021-2028) with COVID Impact Analysis

      $ 3,475.00
      Wearable Patch Market By Technology Outlook(Regular Wearable, Connected Wearable), By Application (Clinical, Non-clinical) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028 Report Code: EB_LS_310| Page: 153| Published Date: March 2021
      Add to cart
      Quick view
      Life Science

      Track and Trace Solutions Market Analysis and Global Forecast (2021-2028) with COVID Impact Analysis

      $ 3,475.00
      Track and Trace Solutions Market By Product Type (Hardware Components, Software, Standalone Platforms, Tracking, Tracing and Reporting Solutions), By Application (Serialization Solutions, Medical Devices Serialization Aggregation Solution) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028 Report Code: EB_LS_332| Page: 163| Published Date: March 2021
      Add to cart
      Quick view
      Life Science

      Proteomics Market Analysis and Global Forecast (2021-2028) with COVID Impact Analysis

      $ 3,475.00
      Proteomics Market By Component (Instruments, Reagents, Services,), By Application (Drug Discovery, Diseases Diagnosis) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028 Report Code: EB_LS_331 | Page: 162 | Published Date: March 2021
      Add to cart
      Quick view
      Healthcare

      Global Electroencephalography (EEG) Equipment Market

      $ 3,475.00
      Electroencephalography (EEG) Equipment Market By Product (EEG Equipment, EEG Accessories) By Application (Diseases Diagnosis, Sleep Monitoring, Anesthesia Monitoring, Trauma & Surgery, Others) By End User (Hospitals, Diagnostic Centers, Surgical Centers, Research Laboratories, Others) and By Geography: Global trends, opportunities and forecast – 2020 to 2026
      Add to cart
      Quick view
      Life Science

      IVF Services Market Analysis and Global Forecast (2021-2028) with COVID Impact Analysis

      $ 3,475.00

      IVF Services Market By Gender (Male, Female), By Procedure (ICSI IVF, Non-ICSI IVF, IUI), By End User (Fertility Clinics, Hospitals, Others) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028

      Report Code: EB_LS_319| Page: 155 | Published Date: March 2021
      Add to cart
      Quick view
      Life Science

      Oncology information systems Market Analysis and Global Forecast (2020-2028) with COVID Impact Analysis

      $ 3,475.00
      Oncology information systems Market By Application (Radiation Oncology, Medical Oncology, Surgical Oncology, ), By Product (Software, Services) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028 Report Code: EB_LS_335| Page: 167 | Published Date: March 2021
      Add to cart
      Quick view
      Life Science

      Aesthetic Lasers And Energy Devices Market Analysis and Global Forecast (2021-2028) with COVID Impact Analysis

      $ 3,475.00

      Global Aesthetic Lasers And Energy Devices Market By Product Type (Laser Resurfacing Devices, Body Contouring Devices, Aesthetic Ophthalmology Device), By Application (Hair removal, Scar Removal, Skin Rejuvenation, Skin Tightening) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028

      Report Code: EB_LS_320 | Page: 171 | Report Status: Upcoming
      Add to cart
      Quick view